Table 9.
% Activity remaining at 1 μM (IC50)a | % control at 1 μMb | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PfARK1 | PfARK3 | PfCDPK2 | PfCDPK5 | PfGSK3 | PfNEK1 | PfNEK3 | PfPK5 | PfPK6 | PfPK9 | PfPKB | PfCDPK1 | PfPK5 | |
67 | 97 | 100 | 88 | 91 | 97 | 100 | 82 | 97 | 2 (13 nM) | 99 | 30 | 51 | 84 |
68 | 98 | 100 | 96 | 98 | 100 | 100 | 84 | 100 | 1 (29 nM) | 100 | 38 | n.d. | n.d. |
75 | 94 | 97 | 78 | 25 | 30 | 100 | 6 | 94 | 0 (1.9 nM)c | 79 | 20 | n.d. | n.d. |
79 | 100 | 87 | 64 | 27 | 34 | 100 | 7 | 94 | 1 (1.6 nM)c | 89 | 21 | 1.1 | 80 |
Results presented as mean values from experiments using the KinaseSeeker assay performed in duplicate. Variability between individual values is less than 10%. IC50 values were determined using the KinaseSeeker assay with 5-fold dilutions, presented as mean values of two experiments performed in duplicate.
Results from DiscoverX KINOMEscan® profiling service.
IC50 values approach the kinase concentration in the assay. IC50s < 5 nM treated as equipotent. n.d. = not determined.